scholarly article | Q13442814 |
P2093 | author name string | Sepideh Peyvandi | |
Farshad Naghshvar | |||
Narges Moslemi Zadeh | |||
Parand Gheshlaghi | |||
Sara Ehetshami | |||
P2860 | cites work | Functional analyses of placental protein 13/galectin-13 | Q28249207 |
Placental protein 13 (PP-13): effects on cultured trophoblasts, and its detection in human body fluids in normal and pathological pregnancies. | Q34326623 | ||
First-trimester placental protein 13 screening for preeclampsia and intrauterine growth restriction | Q34647428 | ||
First-trimester placental protein 13, PAPP-A, uterine artery Doppler and maternal characteristics in the prediction of pre-eclampsia | Q35124240 | ||
Potential markers of preeclampsia--a review | Q37278804 | ||
First-trimester maternal serum PP13 in the risk assessment for preeclampsia. | Q37444801 | ||
Hemodynamic and hemorheological profiles in women with proteinuric hypertension of pregnancy and in pregnant controls | Q38763456 | ||
Women with preeclampsia have increased serum levels of pregnancy-associated plasma protein A (PAPP-A), inhibin A, activin A and soluble E-selectin | Q44369600 | ||
Screening for placental insufficiency in high-risk pregnancies: is earlier better? | Q47849025 | ||
First trimester maternal serum placental protein 13 for the prediction of pre-eclampsia in women with a priori high risk | Q47872838 | ||
Increased levels of pregnancy-associated plasma protein-A2 in the serum of pre-eclamptic patients. | Q54515085 | ||
First-trimester maternal serum pregnancy-associated plasma protein-A and pre-eclampsia | Q61826563 | ||
First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia | Q79409207 | ||
Maternal serum sFlt1 concentration is an early and reliable predictive marker of preeclampsia | Q80496353 | ||
A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound | Q82068160 | ||
Screening for preeclampsia using first-trimester serum markers and uterine artery Doppler in nulliparous women | Q84689681 | ||
P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
P6216 | copyright status | copyrighted | Q50423863 |
P921 | main subject | pre-eclampsia | Q61335 |
P304 | page(s) | 263871 | |
P577 | publication date | 2012-06-18 | |
P1433 | published in | ISRN Obstetrics & Gynecology | Q26842255 |
P1476 | title | PP13 and PAPP-A in the First and Second Trimesters: Predictive Factors for Preeclampsia? | |
P478 | volume | 2012 |
Q43768827 | Association between first-trimester maternal serum pregnancy-associated plasma protein-A and obstetric complications |
Q35714000 | Evaluation of serum β-hCG and PAPP-A levels in pregnant women at risk of developing preeclampsia |
Q28081459 | Galectins: Double-edged Swords in the Cross-roads of Pregnancy Complications and Female Reproductive Tract Inflammation and Neoplasia |
Q37105141 | Investigating the Relationship between Serum Level of s-Met (Soluble Hepatic Growth Factor Receptor) and Preeclampsia in the First and Second Trimesters of Pregnancy |
Q26861380 | Placental Protein 13 (PP13) - A Placental Immunoregulatory Galectin Protecting Pregnancy |
Q55689583 | Placental protein 13: An important biological protein in preeclampsia. |
Q34453242 | Preeclampsia from a renal point of view: Insides into disease models, biomarkers and therapy |
Q26798011 | Serum screening in first trimester to predict pre-eclampsia, small for gestational age and preterm delivery: systematic review and meta-analysis |
Q90618139 | The Relationship of Pregnancy-Associated Plasma Protein A and Human Chorionic Gonadotropin with Adverse Pregnancy Outcomes: A Prospective Study |
Search more.